Standout Papers

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and ... 2006 2026 2012 2019 1.1k
  1. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy (2010)
    Lee Honigberg, Ashley M. Smith et al. Proceedings of the National Academy of Sciences
  2. Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase (2006)
    Zhengying Pan, Heleen Scheerens et al. ChemMedChem

Immediate Impact

16 by Nobel laureates 11 from Science/Nature 69 standout
Sub-graph 1 of 20

Citing Papers

Recognition in the Domain of Molecular Chirality: From Noncovalent Interactions to Separation of Enantiomers
2022 Standout
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
2022 Standout

Works of Zhengying Pan being referenced

Light-Induced Protein Degradation with Photocaged PROTACs
2019
Macrocyclic oligomers of isophthalic acid and trans-1,2-diaminocyclohexane — building blocks for synthetic peptide receptors
1996

Author Peers

Author Last Decade Papers Cites
Zhengying Pan 1279 1370 689 824 42 3.0k
Erik Verner 1294 880 533 582 29 2.5k
Kumudha Balakrishnan 1173 1514 480 878 52 2.7k
Mint Sirisawad 1233 938 683 754 38 2.3k
Markus Warmuth 1669 876 924 409 47 3.1k
J. Blake Bartlett 1551 547 1154 511 45 2.9k
Steven W. Elmore 3127 460 1179 414 37 4.7k
Juerg Schwaller 2022 565 1192 839 65 3.8k
Sari H. Enschede 2052 1667 1150 1220 46 3.9k
Güllü Görgün 1634 885 1393 672 74 3.8k
Darren R. Veach 1512 835 1004 194 54 3.9k

All Works

Loading papers...

Rankless by CCL
2026